1. Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacologydrug disposition, action, and therapy in infants and children. New Engl J Med 2003; 349: 1157–67
2. Rakhmanina NY, van den Anker J. Pharmacological research in pediatrics: from neonates to adolescents. Adv Drug Deliv Rev 2006; 58: 4–14
3. Committee for Medicinal Products for Human Use (CHMP). Clinical investigations of medicinal products in the paediatric population. Note for guidance on clinical investigation of medicinal products in the paediatric population. EMEA/CHMP/ICH/2711/99 [online]. Available from URL: http://www.emea.europa.eu/pdfs/human/ich/271199en.pdf [Accessed 2007 Dec 13]
4. Committee for Medicinal Products for Human Use (CHMP). Reflection paper: formulations of choice for the paediatric population. EMEA/CHMP/PEG/ 194810/2005 [online]. Available from URL: http://www.emea.europa.eu/pdfs/human/paediatrics/19481005en.pdf [Accessed 2007 Dec 13]
5. Schirm E, Tobi H, Vries TW, et al. Lack of appropriate formulations of medicines for children in the community. Acta Paediatr 2003; 92: 1486–9